Page 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
Imperial Sugar Company (f/k/a Imperial Holly Corporation)
_____________________________________________________________
(Name of Issuer)
COMMON STOCK
_____________________________________________________________
(Title of Class of Securities)
453096-10-9
______________________________________________
(CUSIP Number)
D. J. Smith, Vice President, Secretary and General Counsel,
Archer-Daniels-Midland Company,
4666 Faries Parkway, P. O. Box 1470, Decatur, IL 62525,
Telephone: (217)424-5200
______________________________________________________________
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
September 29, 2000
___________________________________________________
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on
Schedule 13G to report the acquisition which is the subject of
this Schedule 13D, and is filing this schedule because of
Rule 13d-1(b)(3) or (4), check the following box __.
Check the following box if a fee is being paid with the statement
___. (A fee is not required only if the reporting person: (1)
has a previous statement on file reporting beneficial ownership
of more than five percent of the class of securities described in
Item 1; and (2) has filed no amendment subsequent thereto
reporting beneficial ownership of five percent or less of such
class.) (See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits,
should be filed with the commission. See Rule 13d-1(a) for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of Securities, and for any subsequent amendment
containing information which would alter disclosures provided in
a prior cover page.
1
Page 2
This information required on the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that Section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
1 NAME OF REPORTING PERSON
S. S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Archer-Daniels-Midland Company
I.R.S. Identification No. 41-0129150
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP * (a)__
(b)__
3 SEC USE ONLY
4 SOURCE OF FUNDS *
N/A
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(E) __x__
Ref. Appendix I
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
7 SOLE VOTING POWER
Ref. Item 13
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
8 SHARED VOTING POWER
Ref. Item 13
9 SOLE DISPOSITIVE POWER
Ref. Item 13
10 SHARED DISPOSITIVE POWER
Ref. Item 13
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Ref. Item 13
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW(11)EXCLUDES
CERTAIN SHARES * __
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 5%
2
Page 3
14 TYPE OF REPORTING PERSON *
CO
* SEE INSTRUCTIONS BEFORE FILLING OUT!
Signature
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
Statement is true, complete and correct.
Dated: October 3, 2000
ARCHER-DANIELS-MIDLAND COMPANY
/s/D. J. SMITH
By: D. J. Smith
Its Vice President, Secretary and
General Counsel
3
Page 4
APPENDIX I
On October 15, 1996, the Company pled guilty to a two count
information in the Northern District of Illinois pursuant to an
agreement with the Department of Justice. This information
states that the Company engaged in anticompetitive conduct in
connection with the sale of lysine and citric acid. In
connection with its agreement this Company paid the United States
a fine of $70 million with respect to lysine and $30 million with
respect to citric acid.
On May 27, 1998, the Company pled guilty to a three count
indictment in the Federal Court of Canada pursuant to an
agreement with Director of Investigation and Research and the
Attorney General of Canada. The indictment alleged that the
Company engaged in anticompetitive conduct in connection with
lysine and citric acid. The Company paid a fine of $16 million
(Canadian Dollars).
4
